Amplitude Venture Capital
Amplitude Venture Capital is an investment firm.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Amplitude Venture Capital Information
Geographic Data
Address: 3, Place Ville-Marie
City: Montreal
State: quebec
Zip: H3B 0E7
Country: CA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$152M
Social
Twitter
Linkedin
Crunchbase
Metrics
5,041,510Website Global Rank
1,932Website Monthly Traffic
Twitter Followers
Description
Amplitude Venture Capital deploys a growth model that has successfully been used to build Canadian companies with world-class management teams and scale companies to breakout potential. Since 2012 Amplitude&s;s founding team has raised over $700 million of equity capital in private and public markets. Amplitude, with offices in Montreal, Toronto, and Vancouver, launched its first private capital fund in November 2019, a $200-million fund that applies a proven, evidence-based approach to investing in leading Canadian precision medicine companies.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2018 | Shoebox Audiometry | Venture Round | - |
| 7/2021 | Deep Genomics | Series C | 0 |
| 1/2018 | Imagia | Series A | 0 |
| 2/2022 | Congruence Therapeutics | Series A | 0 |
| 4/2023 | Radiant Biotherapeutics | Seed Round | 0 |
| 11/2021 | Prilenia | Series B | 0 |
| 8/2021 | Thryv Therapeutics | Series A | 0 |
| 3/2023 | Congruence Therapeutics | Series A | 0 |
| 4/2022 | DrugBank | Seed Round | 0 |
| 9/2019 | Repare Therapeutics | Series B | 82.5M |
| 9/2018 | PHEMI | Venture Round | 2.8M |
| 2/2021 | Notch Therapeutics | Series A | 85M |
| 5/2021 | Giiant Pharma | Seed Round | 0 |
| 3/2022 | Celsius Therapeutics | Series B | 0 |
| 12/2021 | Valence Discovery | Seed Round | 0 |
| 11/2019 | Milestone Pharmaceuticals | Post-IPO Equity | - |
| 4/2023 | Evommune | Series B | 50M |
| 1/2022 | Gandeeva Therapeutics | Series A | 0 |
| 11/2019 | Zymeworks | Post-IPO Equity | - |
| 4/2023 | Abdera Therapeutics | Series A | - |
| 1/2020 | Deep Genomics | Series B | 40M |
| 4/2023 | Radiant Biotherapeutics | Seed Round | 0 |
| 4/2023 | Abdera Therapeutics | Series A | - |
| 3/2023 | Congruence Therapeutics | Series A | 0 |
| 4/2022 | DrugBank | Seed Round | 0 |
| 3/2022 | Celsius Therapeutics | Series B | 0 |
| 2/2022 | Congruence Therapeutics | Series A | 0 |
| 1/2022 | Gandeeva Therapeutics | Series A | 0 |
| 12/2021 | Valence Discovery | Seed Round | 0 |
| 11/2021 | Prilenia | Series B | 0 |
| 8/2021 | Thryv Therapeutics | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
